EUPRAXIA PHARMACEUTICALS INC.
For the period ended Dec 31, 2024. Filed Mar 20, 2025.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2024 · Filed Mar 20, 2025
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Trading Price and Volume
Trading Price and Volume
The Common Shares are listed and posted for trading on the TSX and Nasdaq under the symbol “EPRX” and the Warrants are listed and posted for trading on the TSX under the symbols “EPRX.WT” and “EPRX.WT.A”.
The following table sets forth the reported high and low prices and the aggregate monthly volume of trading of the Common Shares on the TSX for the year ended December 31, 2024. All amounts in the table are expressed in Canadian dollars:
| High · Low · Volume | |||
|---|---|---|---|
| January 2024 | $6.09 | $5.10 | 362,830 |
| February 2024 | $7.64 | $5.67 | 699,720 |
| March 2024 | $6.67 | $3.89 | 2,258,042 |
| April 2024 | $4.79 | $3.44 | 1,276,470 |
| May 2024 | $4.10 | $3.63 | 505,528 |
| June 2024 | $3.79 | $3.45 | 265,973 |
| July 2024 | $3.99 | $3.25 | 285,613 |
| August 2024 | $4.40 | $3.37 | 384,151 |
| September 2024 | $3.91 | $3.24 | 366,222 |
| October 2024 | $3.73 | $3.07 | 497,933 |
| November 2024 | $5.45 | $3.47 | 1,127,957 |
| December 2024 | $4.95 | $4.13 | 219,587 |
The following table sets forth the reported high and low prices and the aggregate monthly volume of trading of the Common Shares on the Nasdaq for the year ended December 31, 2024. All amounts in the table are expressed in US dollars:
| High · Low · Volume | |||
|---|---|---|---|
| January 2024 | $4.15 | $3.79 | 47,700 |
| February 2024 | $5.58 | $4.32 | 48,080 |
| March 2024 | $4.62 | $2.93 | 51,925 |
| April 2024 | $3.50 | $2.48 | 647,505 |
| May 2024 | $3.19 | $2.68 | 724,891 |
| June 2024 | $3.00 | $2.52 | 218,123 |
| July 2024 | $2.90 | $2.40 | 244,874 |
| August 2024 | $2.93 | $2.39 | 116,224 |
| September 2024 | $2.94 | $2.41 | 77,253 |
| October 2024 | $2.81 | $2.20 | 159,001 |
| November 2024 | $4.08 | $2.50 | 710,229 |
| December 2024 | $3.50 | $2.76 | 213,275 |
The following table sets forth the reported high and low prices and the aggregate monthly volume of trading of the listed “EPRX.WT” Warrants on the TSX for the year ended December 31, 2024. All amounts in the table are expressed in Canadian dollars:
| High · Low · Volume | |||
|---|---|---|---|
| January 2024 | $0.60 | $0.58 | 14,500 |
| February 2024 | $0.85 | $0.50 | 134,300 |
| March 2024 | $0.85 | $0.29 | 38,200 |
| April 2024 | $0.31 | $0.24 | 28,500 |
| May 2024 | $0.27 | $0.27 | 1,200 |
| June 2024 | $0.30 | $0.27 | 22,510 |
| July 2024 | $0.31 | $0.27 | 10,500 |
| August 2024 | $0.28 | $0.28 | 18,000 |
| September 2024 | $0.28 | $0.28 | 2,500 |
| October 2024 | $0.28 | $0.28 | 1,000 |
| November 2024 | $0.30 | $0.30 | 2,500 |
| December 2024 | $0.35 | $0.35 | 37,875 |
The following table sets forth the reported high and low prices and the aggregate monthly volume of trading of the listed “EPRX.WT.A” Warrants on the TSX for the year ended December 31, 2024. All amounts in the table are expressed in Canadian dollars:
| High · Low · Volume | |||
|---|---|---|---|
| January 2024 | $3.50 | $3.50 | 3,400 |
| February 2024 | $3.50 | $3.50 | - |
| March 2024 | $3.05 | $1.50 | 179,650 |
| April 2024 | $1.40 | $1.20 | 4,017 |
| May 2024 | $1.50 | $1.50 | 49,200 |
| June 2024 | $1.77 | $1.46 | 11,010 |
| July 2024 | $1.46 | $1.46 | 1,000 |
| August 2024 | $1.46 | $1.46 | - |
| September 2024 | $1.46 | $1.46 | - |
| October 2024 | $1.46 | $1.46 | - |
| November 2024 | $1.45 | $1.20 | 1,300 |
| December 2024 | $1.74 | $1.50 | 8,100 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.